Personal Story
Medicare Patient With Diabetes Will Save Thousands With Insulin Copay Cap
A Missouri woman with Type 1 diabetes can afford to purchase a home with the incoming savings from the Inflation Reduction Act’s insulin copay cap.
Media Contact
As the price of insulin surged for more than a decade, patients with diabetes had no choice but to pay thousands of dollars in copays or risk comas by rationing insulin. For Missouri resident Robin Craycroft, the price of her insulin under Medicare brought her to shock and tears at the pharmacy.
Robin Craycroft is pictured in August 2022. (Photo credit: Robin Craycroft)
When Robin was 61 years old, she was diagnosed with latent autoimmune diabetes—a condition that causes Type 1 diabetes. After she enrolled in Medicare last year at age 65, her insulin costs went from $35 per month to more than $1,000 upon hitting the Medicare coverage gap. The first time Robin saw the price, she teared up in the pharmacy line. The only thing she could do was hand over her credit card to purchase her insulin and pay it off over time. She wants to retire, but the high cost of her prescription medications requires her to continue working part time. Once she heard about the Biden administration enacting the Inflation Reduction Act to cap insulin copays at $35 per month, she cried tears of joy. In anticipation of thousands of dollars in savings, Robin and her husband plan to purchase a home and enjoy retirement unburdened by the stress of rising insulin costs.
With my insulin costs capped at $35 a month, my husband and I can finally save to purchase a house. We are thrilled. Instead of crying in the pharmacy, I am crying tears of joy.Robin Craycroft
Robin and millions of other Medicare recipients with diabetes will finally have relief from high insulin prices with the $35 copay cap from the Inflation Reduction Act. The provision will not just save money; it will save lives.
Read more on how laws passed under Biden have helped Americans
This collection features stories from Americans across the country whose lives and communities have benefited from the legislative and executive actions passed under the Biden administration.
The positions of American Progress, and our policy experts, are independent, and the findings and conclusions presented are those of American Progress alone. A full list of supporters is available here. American Progress would like to acknowledge the many generous supporters who make our work possible.